-
Posted by
Two Blokes Jun 18 -
Filed in
Stock
-
6 views
AMN Healthcare is undervalued, trading at 3.02x FWD cash flow, with strong demand in therapy and imaging specialties supporting future growth. AI investments and normalization post-COVID-19 are expected to enhance service offerings and drive free cash flow improvements in the coming years. Debt reduction has lowered interest expenses, and a large stock repurchase program signals management's confidence in the company's intrinsic value.
